Australia, June 23 -- MAXIGEN BIOTECH Inc., owns the trademark (2603683) for 'MBI' and 'DOT ATOP RECTANGLE,DIVIDED IS LTR I' till Nov. 13, 2035.
Status: registered:
Registered/protected
Class: 5 [viscoelastic agents for ophthalmic purposes; pre-filled syringes with sodium and hyaluronic acid for medical use; collagen for medical purposes; eye drops; ophthalmic preparations; pharmaceuticals for ophthalmological use; eyepatches for medical purposes; pharmaceutical preparations for ocular or intraocular surgery; injectable dermal fillers; skin hydrators being injectable dermal fillers; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; bone cement for surgical and orthopaedic purposes; bone void fillers comprised of living tissues; bone fillers consisting of living materials; bone growth media consisting of biological materials for medical purposes; wadding for medical purposes; materials for dental fillings; dressings, medical; surgical dressings; sterile dressings; medicated tooth cleaning gels; dental adhesives; materials for tooth restoration; teeth filling materials; gelatine for medical purposes; massage gels for medical purposes; aloe vera gels for therapeutic purposes; anti-itch ointments]
Type of Mark: Figurative
Date of Acceptance: Jan. 6
Registration Advertised: June 22
For further details contact Charles Cheung.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2603683.
Disclaimer: Curated by HT Syndication.
